GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Allarity Therapeutics Inc (FRA:C6D0) » Definitions » PB Ratio

Allarity Therapeutics (FRA:C6D0) PB Ratio : (As of Jun. 21, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Allarity Therapeutics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-21), Allarity Therapeutics's share price is €1383.04. Allarity Therapeutics's Book Value per Share for the quarter that ended in Mar. 2024 was €-21.42. Hence, Allarity Therapeutics's PB Ratio of today is .

The historical rank and industry rank for Allarity Therapeutics's PB Ratio or its related term are showing as below:

During the past 5 years, Allarity Therapeutics's highest PB Ratio was 3.79. The lowest was 0.00. And the median was 0.00.

FRA:C6D0's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.35
* Ranked among companies with meaningful PB Ratio only.

Back to Basics: PB Ratio


Allarity Therapeutics PB Ratio Historical Data

The historical data trend for Allarity Therapeutics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allarity Therapeutics PB Ratio Chart

Allarity Therapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
- - 139.70 - -

Allarity Therapeutics Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Allarity Therapeutics's PB Ratio

For the Biotechnology subindustry, Allarity Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allarity Therapeutics's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Allarity Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Allarity Therapeutics's PB Ratio falls into.



Allarity Therapeutics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Allarity Therapeutics's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=1383.04/-21.42
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Allarity Therapeutics  (FRA:C6D0) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Allarity Therapeutics PB Ratio Related Terms

Thank you for viewing the detailed overview of Allarity Therapeutics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Allarity Therapeutics (FRA:C6D0) Business Description

Traded in Other Exchanges
Address
24 School Street, 2nd Floor, Boston, MA, USA
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improve clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.

Allarity Therapeutics (FRA:C6D0) Headlines

No Headlines